169 related articles for article (PubMed ID: 36171346)
1. Design, Fabrication and Evaluation of Stabilized Polymeric mixed micelles for Effective Management in Cancer Therapy.
Chary PS; Rajana N; Devabattula G; Bhavana V; Singh H; Godugu C; Guru SK; Singh SB; Mehra NK
Pharm Res; 2022 Nov; 39(11):2761-2780. PubMed ID: 36171346
[TBL] [Abstract][Full Text] [Related]
2. Enhancing breast cancer treatment: Comprehensive study of gefitinib-loaded poloxamer 407/TPGS mixed micelles through design, development, in-silico modelling, In-Vitro testing, and Ex-Vivo characterization.
Chary PS; Bansode A; Rajana N; Bhavana V; Singothu S; Sharma A; Guru SK; Bhandari V; Mehra NK
Int J Pharm; 2024 May; 657():124109. PubMed ID: 38626846
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of a novel drug delivery: Soluplus
Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L
Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
[TBL] [Abstract][Full Text] [Related]
4. Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment.
Wu H; Zhong Q; Zhong R; Huang H; Xia Z; Ke Z; Zhang Z; Song J; Jia X
Int J Nanomedicine; 2016; 11():6337-6352. PubMed ID: 27932881
[TBL] [Abstract][Full Text] [Related]
5. Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer.
Saxena V; Hussain MD
Int J Nanomedicine; 2012; 7():713-21. PubMed ID: 22359450
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Ezetimibe Anticancer Activity Through Development of Drug Nano-Micelles Formulations: A Promising Strategy Supported by Molecular Docking.
Ahmed TA; Ali EMM; Omar AM; Almehmady AM; El-Say KM
Int J Nanomedicine; 2023; 18():6689-6703. PubMed ID: 38026536
[TBL] [Abstract][Full Text] [Related]
7. Formulation and performance evaluation of polymeric mixed micelles encapsulated with baicalein for breast cancer treatment.
Srivastava S; Kumar A; Yadav PK; Kumar M; Mathew J; Pandey AC; Chourasia MK
Drug Dev Ind Pharm; 2021 Sep; 47(9):1512-1522. PubMed ID: 34781796
[TBL] [Abstract][Full Text] [Related]
8. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer.
Saxena V; Hussain MD
J Biomed Nanotechnol; 2013 Jul; 9(7):1146-54. PubMed ID: 23909128
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers.
Patra A; Satpathy S; Shenoy AK; Bush JA; Kazi M; Hussain MD
Int J Nanomedicine; 2018; 13():2869-2881. PubMed ID: 29844670
[TBL] [Abstract][Full Text] [Related]
10. D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.
Tan X; Fang Y; Ren Y; Li Y; Wu P; Yang X; Liu W
Int J Nanomedicine; 2019; 14():1255-1268. PubMed ID: 30863058
[TBL] [Abstract][Full Text] [Related]
11. An approach for an enhanced anticancer activity of ferulic acid-loaded polymeric micelles via MicroRNA-221 mediated activation of TP53INP1 in caco-2 cell line.
Sweed NM; Dawoud MHS; Aborehab NM; Ezzat SM
Sci Rep; 2024 Jan; 14(1):2073. PubMed ID: 38267567
[TBL] [Abstract][Full Text] [Related]
12. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy.
Zhao J; Xu Y; Wang C; Ding Y; Chen M; Wang Y; Peng J; Li L; Lv L
Drug Dev Ind Pharm; 2017 Jul; 43(7):1197-1204. PubMed ID: 28300426
[TBL] [Abstract][Full Text] [Related]
13. Pluronic-Based Mixed Polymeric Micelles Enhance the Therapeutic Potential of Curcumin.
Akbar MU; Zia KM; Nazir A; Iqbal J; Ejaz SA; Akash MSH
AAPS PharmSciTech; 2018 Aug; 19(6):2719-2739. PubMed ID: 29978290
[TBL] [Abstract][Full Text] [Related]
14. Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells.
Zuo R; Zhang J; Song X; Hu S; Gao X; Wang J; Ji H; Ji C; Peng L; Si H; Li G; Fang K; Zhang J; Jiang S; Guo D
Int J Nanomedicine; 2021; 16():1587-1600. PubMed ID: 33664573
[TBL] [Abstract][Full Text] [Related]
15. A novel mixed polymeric micelle for co-delivery of paclitaxel and retinoic acid and overcoming multidrug resistance: synthesis, characterization, cytotoxicity, and pharmacokinetic evaluation.
Emami J; Rezazadeh M; Mashayekhi M; Rostami M; Jahanian-Najafabadi A
Drug Dev Ind Pharm; 2018 May; 44(5):729-740. PubMed ID: 29235901
[TBL] [Abstract][Full Text] [Related]
16. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines.
Gill KK; Kaddoumi A; Nazzal S
Eur J Pharm Sci; 2012 May; 46(1-2):64-71. PubMed ID: 22369858
[TBL] [Abstract][Full Text] [Related]
17. Formulation and in vitro evaluation of quercetin loaded polymeric micelles composed of pluronic P123 and D-a-tocopheryl polyethylene glycol succinate.
Zhao L; Shi Y; Zou S; Sun M; Lil L; Zhail G
J Biomed Nanotechnol; 2011 Jun; 7(3):358-65. PubMed ID: 21830476
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.
Yang L; Zhang Z; Hou J; Jin X; Ke Z; Liu D; Du M; Jia X; Lv H
Int J Nanomedicine; 2017; 12():7653-7667. PubMed ID: 29089761
[TBL] [Abstract][Full Text] [Related]
19. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.
Wei Z; Hao J; Yuan S; Li Y; Juan W; Sha X; Fang X
Int J Pharm; 2009 Jul; 376(1-2):176-85. PubMed ID: 19409463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]